About this trial
The objective of this clinical trial is to explore the correlation between the level of microplastic exposure and the risk of gastric mucosal carcinogenesis, and to evaluate the strength of its effect as an independent risk factor. The main questions it aims to answer include: Does the level of microplastic exposure increase the risk of gastric mucosal carcinogenesis? Can the correlation between the level of microplastic exposure and gastric mucosal carcinogenesis, as well as the sources of high - risk microplastic exposure, be explored through a questionnaire on external microplastic exposure? Researchers will complete a design structured questionnaire and ask participants to fill it out carefully and truthfully to determine whether the level of microplastic exposure increases the risk of gastric mucosal carcinogenesis.
Eligibility criteria
Qualifiers
Aged between 18 and 75 years old, gender is not restricted
Having a clear diagnosis result within the recent three months and being diagnosed with chronic non - atrophic gastritis, precancerous lesions of gastric cancer, or gastric cancer for the first time
Have clear Helicobacter pylori (Hp) test results
Be in normal mental state and able to independently complete the questionnaire survey
Disqualifiers
Patients with a history of malignant tumors in other parts
Patients who have previously undergone upper gastrointestinal surgery, chemotherapy, or radiotherapy
Patients with severe diseases of major organs such as the heart, lungs liver, and kidneys
Patients who are currently receiving psychological intervention or taking psychiatric drugs
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Yongquan Shi
Lead sponsor
Xijing Hospital of Digestive Diseases
Sponsor institution